Patents by Inventor Clifford DiLea

Clifford DiLea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER TREATMENT WITH EPOTHILONES
    Publication number: 20090069394
    Abstract: The present invention relates to an in vivo regimen for the treatment of a proliferative disease, including non small cell lung carcinoma, where an epothilone, including epothiline B, is administered in a loading dose followed by at least one maintenance doses.
    Type: Application
    Filed: November 12, 2008
    Publication date: March 12, 2009
    Inventors: Clifford Dilea, Paul M.J. Mcsheehy, Sauveur-Michel Maira, Chiaki Tanaka, Markus Wartmann
  • Use of an anti-endotoxin drug in the prevention and treatment of disease
    Patent number: 7348316
    Abstract: The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: March 25, 2008
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Daniel P. Rossignol, Melvyn Lynn, Clifford DiLea
  • Cancer treatment with epothilones
    Publication number: 20060235059
    Abstract: The present invention relates to an in vivo regimen for the treatment of a proliferative disease, where an epothilone, is administered in a loading dose followed by at least 1, maintenance doses.
    Type: Application
    Filed: September 1, 2004
    Publication date: October 19, 2006
    Inventors: Clifford Dilea, Paul McSheehy, Sauveur-Michel Maira, Chiaki Tanaka, Markus Wartmann
  • Use of an anti-endotoxin drug in the prevention and treatment of disease
    Publication number: 20050153929
    Abstract: The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.
    Type: Application
    Filed: December 13, 2004
    Publication date: July 14, 2005
    Inventors: Daniel Rossignol, Melvyn Lynn, Clifford DiLea
  • Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
    Publication number: 20030105033
    Abstract: The invention provides methods for administering an anti-endotoxin drug, E5564, by bolus or intermittent intravenous infusion. The methods can be used for treating conditions such as endotoxemia, sepsis, and septic shock.
    Type: Application
    Filed: June 13, 2002
    Publication date: June 5, 2003
    Inventors: Daniel P. Rossignol, Melvyn Lynn, Clifford DiLea
  • Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
    Publication number: 20020042379
    Abstract: The invention provides methods for administering an anti-endotoxin drug, E5564, by bolus or intermittent intravenous infusion. The methods can be used for treating conditions such as endotoxemia, sepsis, and septic shock.
    Type: Application
    Filed: June 11, 2001
    Publication date: April 11, 2002
    Inventors: Daniel Rossignol, Melvyn Lynn, Clifford DiLea